NPM1 and acute myeloid leukemia: Furthermore, similar to exon 12 mutations, exon 5 NPM1 mutations can be followed either by RT‐PCR based assays [11] or highly sensitive error corrected next‐generation sequencing [12] to monitor measurable residual disease to obtain definitive information on the impact of NPM1 exon 5 mutations in AML prognosis.